Tedros Adhanom Ghebreyesus, Director of the World Health Organization told the media late on Wednesday that the World Health Organization and Indian authorities are investigating the New Delhi-based drug maker Maiden Phatmaceuticals Ltd. After the test results, it was found that this company’s cough syrup can cause small children In the Gambia, dozens of people have serious kidney problems. until death
Maiden Pharmaceuticals declined to comment on the matter. while the Drug Controller General of India and the Ministry of Health has not come out to clarify any details as well.
However, a source from India’s Ministry of Health told Reuters on October 6 that the government had asked the World Health Organization for information. It shows that the cough syrup is linked to child deaths in the Gambia.
WHO has issued a warning to withdraw four Maiden Pharmaceuticals cold medicine products. Off the shelves were Promathezine Oral Solution, Kofexmalin Infant Cough Syrup, Makoff Infant Cough Syrup and Magrip N Cold Syrup, after laboratory tests revealed diethylene glycol and ethylene glycol ethylene glycol, which is banned in food, in quantities ” more than acceptable”, is dangerous and can cause serious kidney damage.
Gambian medical workers began meeting the children. Dozens of people have had kidney problems since July, but the group of under-fives developed symptoms three to five days after taking cold syrup and cough syrup.
Mustafa Bittaye, director of the Gambia Health Service, said other syrups were also available. encountered a similar problem. The Ministry of Public Health is awaiting the results of the confirmation.